PF-3882845

PF-3882845
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16502-25mg 25 mg

7 - 10 business days*

470.00€
TGM-T16502-50mg 50 mg

7 - 10 business days*

786.00€
 
Description: PF-3882845 also binds to the progesterone receptor (the binding IC50: 310 nM).... more
Product information "PF-3882845"
Description: PF-3882845 also binds to the progesterone receptor (the binding IC50: 310 nM). PF-3882845 is a remarkably high affinity selective and orally efficacious mineralocorticoid receptor (MR binding IC50=2.7 nM) antagonist for hypertension and nephropathy. Target: Others. Smiles: ClC=1C=C(N2[C@H]([C@@]3(C(=N2)C=4C(CC3)=CC(C(O)=O)=CC4)[H])C5CCCC5)C=CC1C#N. References: Meyers MJ, et al. Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy. J Med Chem. 2010 Aug 26,53(16):5979-6002.
Supplier: TargetMol
Supplier-Nr: T16502

Properties

MW: 419.9 D
Formula: C24H22ClN3O2

Database Information

CAS : 1023650-66-9| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H315, H319, H335
P Phrases: P261, P264, P271, P280, P302+352, P304+340, P305+351+338, P312, P321, P332+313, P337+313, P362+364, P403+233, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PF-3882845"
Write a review
or to review a product.
Viewed